Trial Profile
Phase I Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Feb 2017
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 12 Dec 2009 New trial record